Dare Bioscience (DARE) News Today $2.43 +0.01 (+0.25%) As of 10:10 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DARE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Daré Bioscience, Inc.: Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY Sildenafil CreamJuly 29, 2025 | finanznachrichten.deDaré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil CreamJuly 29, 2025 | finance.yahoo.comDaré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil CreamJuly 29, 2025 | globenewswire.comUPDATE - Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the BarJuly 21, 2025 | globenewswire.comDaré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the BarJuly 21, 2025 | finance.yahoo.comDaré Bioscience, Inc.: Positive Interim Phase 3 Results Highlight Potential of Ovaprene, Novel Hormone-Free ContraceptiveJuly 15, 2025 | finanznachrichten.deDare Bioscience Analyst Ratings and Price Targets | NASDAQ:DARE | BenzingaJuly 15, 2025 | benzinga.comDaré Bioscience Shares Soar on Data From Phase 3 Contraceptive StudyJuly 15, 2025 | marketwatch.comCrude Oil Moves Lower; Daré Bioscience Shares JumpJuly 14, 2025 | benzinga.comPositive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free ContraceptiveJuly 14, 2025 | globenewswire.comDaré Bioscience, Inc.: Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for ...July 12, 2025 | finanznachrichten.deDaré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic DisordersJuly 11, 2025 | globenewswire.comDARE Daré Bioscience, Inc. - Seeking AlphaJuly 3, 2025 | seekingalpha.comDaré Bioscience Announces Adjournment of Annual Meeting of StockholdersJune 12, 2025 | globenewswire.comDaré Bioscience, Inc.: Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company UpdateMay 17, 2025 | finanznachrichten.deQ1 2025 Dare Bioscience Inc Earnings CallMay 16, 2025 | finance.yahoo.comDaré Bioscience outlines $4.5B hormone therapy market entry and expects Q4 2025 revenue as dual path strategy expandsMay 14, 2025 | seekingalpha.comDaré Bioscience, Inc. (DARE) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comDaré Bioscience Reports First Quarter 2025 Financial Results and Provides Company UpdateMay 13, 2025 | globenewswire.comDare Bioscience's Earnings OutlookMay 12, 2025 | benzinga.comDrug Development Is Slowing Down After Cuts at the FDAApril 17, 2025 | msn.comDare Bioscience to present on expanded business strategy at Jones ConferenceApril 8, 2025 | markets.businessinsider.comMaxim Group Keeps Their Hold Rating on Daré Bioscience (DARE)April 5, 2025 | markets.businessinsider.comQ4 2024 Dare Bioscience Inc Earnings CallApril 1, 2025 | finance.yahoo.comDaré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comDare Bioscience expects to start recording revenue, cash flow in Q425April 1, 2025 | markets.businessinsider.comDaré Bioscience targets Q4 2025 for Sildenafil Cream launch via 503B compoundingMarch 31, 2025 | msn.comDaré Bioscience, Inc. (DARE) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comDaré Bioscience Reports Full Year 2024 Financial Results and Provides Company UpdateMarch 31, 2025 | globenewswire.comDare Bioscience Q4 2024 Earnings PreviewMarch 30, 2025 | msn.comA Look Ahead: Dare Bioscience's Earnings ForecastMarch 28, 2025 | benzinga.comDaré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025March 24, 2025 | globenewswire.comDaré Bioscience and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive ImplantFebruary 20, 2025 | finance.yahoo.comDare Bioscience risks Nasdaq delisting over market valueFebruary 14, 2025 | msn.comDare Bioscience secures additional NIAID funding for HPV treatmentFebruary 6, 2025 | msn.comDaré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV DevelopmentFebruary 6, 2025 | globenewswire.comDaré Bioscience to Participate in the Women’s Health Series at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 9, 2025 | markets.businessinsider.comDaré Bioscience to Participate in the Women's Health Series at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 9, 2025 | globenewswire.comOptimistic Buy Rating for Daré Bioscience Driven by Strategic Progress and Financial PositionDecember 18, 2024 | markets.businessinsider.comDaré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD)December 16, 2024 | markets.businessinsider.comDare Bioscience received payment of $2.5M under grant agreementDecember 5, 2024 | markets.businessinsider.comDaré Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1December 4, 2024 | finance.yahoo.comDaré Bioscience, Inc.: Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company UpdateNovember 16, 2024 | finanznachrichten.deDare Bioscience files to sell 2.75M shares of common stock for holdersNovember 16, 2024 | markets.businessinsider.comQ3 2024 Dare Bioscience Inc Earnings CallNovember 16, 2024 | finance.yahoo.comMaxim Group Remains a Hold on Daré Bioscience (DARE)November 16, 2024 | markets.businessinsider.comDare Bioscience Inc (DARE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...November 15, 2024 | uk.finance.yahoo.comDaré Bioscience: Advancing Women’s Health InnovationsNovember 15, 2024 | markets.businessinsider.comDaré Bioscience, Inc. (DARE) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comDaré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company UpdateNovember 14, 2024 | globenewswire.com Get Dare Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter. Email Address DARE Media Mentions By Week DARE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DARE News Sentiment▼0.720.46▲Average Medical News Sentiment DARE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DARE Articles This Week▼41▲DARE Articles Average Week Get Dare Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Adaptimmune Therapeutics News Virios Therapeutics News Vaxart News Metagenomi News VistaGen Therapeutics News Oramed Pharmaceuticals News Artiva Biotherapeutics News XBiotech News Entera Bio News Milestone Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DARE) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dare Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dare Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DARE Stock Alerts